Eosinophilic gastrointestinal disorders (EGIDs) are a group of rare conditions that affect the digestive system.…
The American College of Gastroenterology recently published its latest Monograph on Management of Irritable Bowel Syndrome (IBS) in The American Journal of Gastroenterology.
Treating IBS can be challenging because no “validated treatment algorithm exists,” the authors write, “patients with similar symptoms frequently respond to the same treatment differently,” and some patients do not respond to therapy. However, novel therapeutic strategies and new compounds have been introduced since the monograph’s last iteration. As a result, the monograph is intended “to provide an updated, evidence-based document on the therapy of this common and, at times, debilitating disorder.”
Among the highlights of the new monograph include summary of evidence from randomized controlled trials of pharmacological, psychological and dietary therapies in IBS.
Authors for the ACG Task Force on Management of Irritable Bowel Syndrome
- Alexander C. Ford MB ChB, MD
- Paul Moayyedi BSc, MB ChB, PhD, MPH, FACG
- William D. Chey MD, FACG
- Lucinda A. Harris MD, FACG,
- Brian E. Lacy MD, PhD, FACG,
- Yuri A. Saito MD, MPH, FACG
- Eamonn M. M. Quigley MD, MACG